Search for: "Janssen Pharmaceuticals Inc." Results 61 - 80 of 195
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jan 2012, 11:57 am
Risperdal was created by Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, and has been on the market for several years. [read post]
8 Sep 2015, 1:15 pm by Tom Lamb
Given these numerous case reports made to Health Canada and documented in medical articles, one wonders whether the responsible drug company, Janssen Pharmaceuticals, Inc., should increase the drug label warnings about hepatic / liver side effects such as acute liver failure, which can be fatal in some instances. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 9/4: Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd., Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
13 Aug 2009, 4:07 am
Janssen Pharmaceutical, Inc., ___ A.2d ___, 2009 WL 1857395 (Pa. [read post]
28 Feb 2014, 9:27 pm by Legal Reader
(Hereinafter “Janssen”); (2) Johnson & Johnson; (3) Johnson & Johnson Pharmaceutical Research & Development, L.L.C; (4) Excerpta Medica Inc.; and (5) Elsevier Inc. [read post]
16 Apr 2012, 8:26 pm
Nevertheless, Janssen Pharmaceuticals, Inc. – a division of Johnson & Johnson – neglected to tell physicians of the risks associated with the drug, even downplaying side effects in some instances, reports Bloomberg Businessweek. [read post]
31 Jan 2013, 7:30 am by Gene Quinn & Angel Krippner
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
1 Mar 2013, 6:28 am by Gene Quinn
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
26 Jun 2013, 6:30 am by Gene Quinn
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
24 Oct 2014, 7:56 am
Janssen Pharmaceuticals, Inc., No. 3:12-oe-40003, 2014 U.S. [read post]
24 Jan 2012, 8:29 am by Mark Zamora
., which is where the settlement was announced.The Texas court case was just one of dozens involving the J&J and its Janssen Pharmaceuticals subsidiary. [read post]
6 May 2016, 8:00 am by Robert Kreisman
Related blog posts: $124 Million Penalty to Stand Against the Drug Maker Janssen for the Drug Risperdal $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug Xarelto Lawsuits are Underway in Multi-district Litigation in the U.S. [read post]
21 Jun 2015, 6:17 pm by Ed. Microjuris.com Puerto Rico
Por estas razones, se desestimaron las causas de acción y de igual manera las causas de acción bajo las leyes locales contra Johnson & Johnson Services, Inc., Janssen Cilag Mfg., LLC; Janssen Ortho, LLC. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]